<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02668627</url>
  </required_header>
  <id_info>
    <org_study_id>SMC 2013-12-088</org_study_id>
    <nct_id>NCT02668627</nct_id>
  </id_info>
  <brief_title>MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)</brief_title>
  <official_title>MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on the results of recent randomized controlled trials, current international guidelines
      recommend the initiation of endovascular treatment within 6 hours of symptom onset for acute
      ischemic stroke. Endovascular treatment may be beneficial in selected patients beyond 6 hour
      time window. In particular, treatment response to endovascular therapy may be greatly
      influenced by pretreatment collateral status. The aim of this study is to evaluate whether
      MRI-based collateral imaging (the Fast Analysis SysTem for COLLaterals, 'FAST-COLL') is
      feasible and can predict the response to endovascular treatment in a wide range of patients
      with acute ischemic stroke .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>90-days functional outcome</measure>
    <time_frame>90-days</time_frame>
    <description>90-days modified Rankin Scale ≤ 2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early neurologic improvement</measure>
    <time_frame>24 hours</time_frame>
    <description>An 8-point or more improvement on the NIH score when comparing the baseline score or a NIHSS score of 0-1, at 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic hemorrhagic transformation</measure>
    <time_frame>During initial admission</time_frame>
    <description>Occurrence of an increase in the National Institutes of Health Stroke Scale (NIHSS) score of 4 or more points in the setting of local or remote parenchymal hematoma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful recanalization</measure>
    <time_frame>within 24 hours of symptom onset</time_frame>
    <description>Defined as modified Thrombolysis in Cerebral Infarction (mTICI) ≥ 2b</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Stroke</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular treatment</intervention_name>
    <description>Endovascular mechanical thrombectomy or endovascular delivery of thrombolytic agent</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute ischemic stroke, eligible for endovascular treatment within 12 hours of symptom onset
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute ischemic stroke

          -  Age 20 years and older

          -  Disabling stroke defined as a baseline NIHSS &gt; 5 at the time of arrival

          -  Onset (last-seen-well) time to endovascular treatment time &lt; 12 hours

          -  Confirmed symptomatic intracranial occlusion, based on CT or MR angiography, at one or
             more of the following locations: Carotid T/L, M1 MCA, or M1-MCA equivalent (2 or more
             M2-MCAs)

          -  Signed informed consent or appropriate signed deferral of consent where approved

        Exclusion Criteria:

          -  Baseline non-contrast CT reveals a moderate/large core defined as extensive early
             ischemic changes of ASPECTS 0-5 in the territory of symptomatic intracranial
             occlusion.

          -  Clinical history, past imaging or clinical judgment suggests that the intracranial
             occlusion is chronic

          -  Unable to undergo MRI (contraindicated or poor cooperation)

          -  Patient has a severe or fatal comorbid illness that will prevent improvement or
             follow-up or that will render the procedure unlikely to benefit the patient

          -  Pregnant females as determined by positive urine hCG test or lactating females
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oh Young Bang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jong-Won Chung, MD</last_name>
    <phone>82234103599</phone>
    <email>neurocjw@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yun Jeong Lim, RN</last_name>
    <phone>82221489697</phone>
    <email>smcyunjeong@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center, Sungkyunkwan University School of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>135710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong-Won Chung, MD</last_name>
      <phone>82234101895</phone>
      <email>neurocjw@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Oh Young Bang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kwang Ho Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chin-Sang Chung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gyeong-Moon Kim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jong-Won Chung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2016</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Oh Young Bang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Collateral status</keyword>
  <keyword>Endovascular treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

